Home/Filings/4/0000921895-20-002115

4//SEC Filing

COUCHMAN JONATHAN 4

Accession 0000921895-20-002115

CIK 0000727510other

View on SEC.gov Company Profile

Filed

Aug 5, 8:00 PM ET

Accepted

Aug 6, 4:23 PM ET

Size

21.8 KB

Accession

0000921895-20-002115

Insider Transaction Report

Form 4

Period: 2020-08-05

ENZON PHARMACEUTICALS, INC.ENZN

Xstelos Corp.

Other

Transactions

Purchase
Common Stock, $0.01 par value
2020-08-05$0.20/sh+506,292$101,258→ 2,100,524 total(indirect: By Xstelos Corp.)

Holdings

Common Stock, $0.01 par value
(indirect: By Jonathan Couchman)
4,717,666
Common Stock, $0.01 par value
(indirect: By Couchman Family Fund)
400,000
Common Stock, $0.01 par value
(indirect: By Myrexis, Inc.)
633,264
Common Stock, $0.01 par value
(indirect: By LLC)
1,667,294
Common Stock, $0.01 par value
(indirect: By Michael Pearce)
0

HARPER ASSET MANAGEMENT LLC

Other

Transactions

Purchase
Common Stock, $0.01 par value
2020-08-05$0.20/sh+506,292$101,258→ 2,100,524 total(indirect: By Xstelos Corp.)

Holdings

Common Stock, $0.01 par value
(indirect: By Myrexis, Inc.)
633,264
Common Stock, $0.01 par value
(indirect: By Jonathan Couchman)
4,717,666
Common Stock, $0.01 par value
(indirect: By Couchman Family Fund)
400,000
Common Stock, $0.01 par value
(indirect: By LLC)
1,667,294
Common Stock, $0.01 par value
(indirect: By Michael Pearce)
0

Pearce Michael Cooper

Other

Transactions

Purchase
Common Stock, $0.01 par value
2020-08-05$0.20/sh+506,292$101,258→ 2,100,524 total(indirect: By Xstelos Corp.)

Holdings

Common Stock, $0.01 par value
(indirect: By Couchman Family Fund)
400,000
Common Stock, $0.01 par value
(indirect: By LLC)
1,667,294
Common Stock, $0.01 par value
(indirect: By Jonathan Couchman)
4,717,666
Common Stock, $0.01 par value
(indirect: By Myrexis, Inc.)
633,264
Common Stock, $0.01 par value
(indirect: By Michael Pearce)
0

COUCHMAN JONATHAN

10% OwnerOther

Transactions

Purchase
Common Stock, $0.01 par value
2020-08-05$0.20/sh+506,292$101,258→ 2,100,524 total(indirect: By Xstelos Corp.)

Holdings

Common Stock, $0.01 par value
(indirect: By Couchman Family Fund)
400,000
Common Stock, $0.01 par value
(indirect: By Myrexis, Inc.)
633,264
Common Stock, $0.01 par value
(indirect: By Michael Pearce)
0
Common Stock, $0.01 par value
(indirect: By Jonathan Couchman)
4,717,666
Common Stock, $0.01 par value
(indirect: By LLC)
1,667,294

Couchman Family Fund

Other

Transactions

Purchase
Common Stock, $0.01 par value
2020-08-05$0.20/sh+506,292$101,258→ 2,100,524 total(indirect: By Xstelos Corp.)

Holdings

Common Stock, $0.01 par value
(indirect: By Jonathan Couchman)
4,717,666
Common Stock, $0.01 par value
(indirect: By Myrexis, Inc.)
633,264
Common Stock, $0.01 par value
(indirect: By Couchman Family Fund)
400,000
Common Stock, $0.01 par value
(indirect: By LLC)
1,667,294
Common Stock, $0.01 par value
(indirect: By Michael Pearce)
0

Myrexis, Inc.

10% Owner

Transactions

Purchase
Common Stock, $0.01 par value
2020-08-05$0.20/sh+506,292$101,258→ 2,100,524 total(indirect: By Xstelos Corp.)

Holdings

Common Stock, $0.01 par value
(indirect: By Myrexis, Inc.)
633,264
Common Stock, $0.01 par value
(indirect: By Couchman Family Fund)
400,000
Common Stock, $0.01 par value
(indirect: By Jonathan Couchman)
4,717,666
Common Stock, $0.01 par value
(indirect: By LLC)
1,667,294
Common Stock, $0.01 par value
(indirect: By Michael Pearce)
0

Harper Brian James

Other

Transactions

Purchase
Common Stock, $0.01 par value
2020-08-05$0.20/sh+506,292$101,258→ 2,100,524 total(indirect: By Xstelos Corp.)

Holdings

Common Stock, $0.01 par value
(indirect: By Couchman Family Fund)
400,000
Common Stock, $0.01 par value
(indirect: By Jonathan Couchman)
4,717,666
Common Stock, $0.01 par value
(indirect: By Myrexis, Inc.)
633,264
Common Stock, $0.01 par value
(indirect: By LLC)
1,667,294
Common Stock, $0.01 par value
(indirect: By Michael Pearce)
0

Footnotes (7)

[F1]This Form 4 is filed jointly by Jonathan Couchman ("Mr. Couchman"), Couchman Family Fund (the "Foundation"), Xstelos Corp. ("Xstelos") and Myrexis, Inc. ("Myrexis"), Brian Harper, Harper Asset Management, LLC ("HAM"), and Michael Pearce, (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons expressly disclaims beneficial ownership of the Shares reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such Shares for purposes of Section 16 or for any other purpose.
[F2]Represents shares owned directly by Mr. Couchman. As the sole trustee of the Foundation, Mr. Couchman may be deemed to beneficially own the Shares owned by the Foundation. As the Chief Executive Officer of Xstelos, Mr. Couchman may be deemed to beneficially own the shares of Common Stock owned by Xstelos. As the Chief Executive Officer of Myrexis, Mr. Couchman may be deemed to beneficially own Shares of Common Stock owned by Myrexis.
[F3]Represents Shares owned directly by the Foundation. Mr. Couchman is the sole trustee of the Foundation. By virtue of this relationship, Mr. Couchman may be deemed to beneficially own the Shares owned directly by the Foundation, however he has no pecuniary interest in such Shares.
[F4]Represents Shares owned directly by Xstelos. Mr. Couchman is the controlling shareholder and Chief Executive Officer of Xstelos. By virtue of these relationships, Mr. Couchman may be deemed to beneficially own the Shares owned directly by Xstelos. Mr. Couchman expressly disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein.
[F5]Represents Shares owned directly by Myrexis. Mr. Couchman is Chief Executive Officer of Myrexis. By virtue of this relationship, Mr. Couchman may be deemed to beneficially own the Shares owned directly by Myrexis. Mr. Couchman expressly disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein.
[F6]Represents shares owned directly by HAM. Mr. Harper is the President of HAM. By virtue of this relationship, Mr. Harper may be deemed to beneficially own the Shares owned directly by HAM. Mr. Harper expressly disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein.
[F7]Represents shares owned directly by Michael Pearce. Mr. Pearce expressly disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein.

Documents

1 file

4
form405735004_08062020.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

ENZON PHARMACEUTICALS, INC.

CIK 0000727510

→

Entity typeother

Related Parties

filerCIK 0001265094

Filing Metadata

Form type: 4
Filed: Aug 5, 8:00 PM ET
Accepted: Aug 6, 4:23 PM ET
Size: 21.8 KB

View on SEC.gov